EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hypoglycaemic activity of biosynthesized copper oxide nanoparticles in alloxan‐induced diabetic Wister rats

Maimuna Bello Umar, Augustine Innalegwu Daniel iD, Jimoh Oladejo Tijani, Rebecca Olufemi Akinleye, Enriquay Smith, Marshall Keyster, Ashwil Klein

Endocrinology, Diabetes & Metabolism · 2023

DOI: 10.1002/edm2.423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2023. Verfasst von Maimuna Bello Umar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Federal University of Technology, Minna, Nigeria. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Nanoparticles. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes mellitus (DM) is a metabolic disorder that affects the body's ability to produce or use insulin. This study evaluated the hypoglycaemic activity of biosynthesized copper oxide nanoparticles (CuO‐NPs) in alloxan‐induced diabetic Wister rats.

Methods

CuO‐NPs were synthesized via the green route and characterized using different analytical tools. Diabetes was induced intraperitoneally using 90 mg/kg body weight of alloxan monohydrate in albino rats. Thirty (30) rats were randomly divided into 5 groups of 6 rats each and orally treated for 21 days. Groups I and II were treated with 300 mg/kg bwt Cereus hildmannianus extract and CuO‐NPs, respectively. Groups III and IV received 5 mg/kg bwt of Glibenclamide and 2 mL of normal saline, respectively, while Group V was left untreated as the diabetic control. Blood glucose (BG) levels and body weight changes were monitored at 3‐ and 7‐day intervals, respectively, throughout 21‐day treatment period. Lipid profiles, enzyme assays and histopathological studies of the liver were also carried out.

Results

Spheroidal tenorite phase of CuO‐NPs with a crystallite size of 62.57 nm, surface area (20.64 m 2 /g) and a UV‐maximum absorption at 214.27 nm was formed. The diabetic rats treated with 300 mg/kg bwt CuO‐NPs had the highest BG lowering ability (from 482.75 ± 27.70 to 124.50 ± 2.50 mg/dL). A significant difference ( p < 0.05) in weight gain and serum enzymes was also observed in the CuO‐NPs treated group compared with other groups. The CuO‐NPs‐treated group had a significant increase ( p < 0.05) in HDL‐cholesterol and a decrease in total cholesterol, triglycerides, LDL‐cholesterol and VLDL‐cholesterol compared with other groups.

Conclusion

The green synthesized CuO‐NPs nanoparticles significantly reduced ( p < 0.05) blood glucose levels in rats and other associated indices and could serve as drug lead in the treatment of diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalNanoparticlesAnimalsRatsHypoglycemic AgentsCopperAlloxanBlood GlucosePlant ExtractsRats, WistarCholesterol, HDLBody WeightOxides

Stichwörter der Autor:innen

Alloxan monohydrateHistoarchitecturebiosynthesiscopper oxide nanoparticlesdiabetes mellitus

Substanzen

Hypoglycemic Agentscupric oxidecuprous oxideCopperAlloxanBlood GlucosePlant ExtractsCholesterol, HDLOxides

Autor:innen und Institutionen

  • Department of Biochemistry, Federal University of Technology, Minna, Nigeria.
  • Department of Biotechnology, University of the Western Cape, Bellville, South Africa.
  • Department of Chemistry, Federal University of Technology, Minna, Nigeria.

ORCID-Profile: Augustine Innalegwu Daniel

Zitieren

APA

Umar, M. B., Daniel, A. I., Tijani, J. O., Akinleye, R. O., Smith, E., Keyster, M., & Klein, A. (2023). Hypoglycaemic activity of biosynthesized copper oxide nanoparticles in alloxan‐induced diabetic Wister rats. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.423

Vancouver

Umar MB, Daniel AI, Tijani JO, Akinleye RO, Smith E, Keyster M, et al. Hypoglycaemic activity of biosynthesized copper oxide nanoparticles in alloxan‐induced diabetic Wister rats. Endocrinology, Diabetes & Metabolism. 2023. doi:10.1002/edm2.423

BibTeX
@article{Umar2023,
  author = {Umar, Maimuna Bello and Daniel, Augustine Innalegwu and Tijani, Jimoh Oladejo and Akinleye, Rebecca Olufemi and Smith, Enriquay and Keyster, Marshall and Klein, Ashwil},
  title = {Hypoglycaemic activity of biosynthesized copper oxide nanoparticles in alloxan‐induced diabetic Wister rats},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2023},
  doi = {10.1002/edm2.423}
}
Kostenlos starten →